Heart disease and stroke risks could be cut after the world’s first international trial of a “polypill”.
The four-in-one pill contains aspirin as well as chemicals which can lower blood pressure and cholesterol levels.
Millions of people around the world are already being prescribed separate pills in order to reduce their risk of heart attacks and strokes, leading to researchers to consider the combined pill. There have been calls for all over-55s to be encouraged to take it to reduce their risks of ill health.
In a study revealed in the Public Library of Science One, 378 people from the UK, Australia, Brazil, India, Holland, New Zealand and the US, were tested with the polypill who did not already need its components, but who had more than a 7.5% estimated risk of cardiovascular problems.
The drug is composed of 75mg of aspirin, the blood pressure drug lisinopril and hydrochlorothiazide, and simvastatin, which battles cholesterol. The drug did cause some side effects in one in six people, however, with one in 20 halting the treatment owing to outcomes such as irritated stomachs and coughing.